Skip to content
Disclosery

Alerce Investment Management, L.P.

Follow

13F filer, CIK 1844002, Chicago, IL

Alerce Investment Management, L.P. reported $62,320,906 across 5 holdings for the quarter ended 2024-09-30, in a 13F-HR filed 2024-11-13.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000895345-24-000559

Period
2024-09-30
Reported value
$62.3M
Holdings
5
Top 10 weight
100%
New
1
Sold out
1

Largest buys vs the previous quarter

SecurityShares changeApprox. value
AMWLnew+523,785$4.97M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
AMERICAN WELL CORPexited-10,475,717-$3.4M
WHWKreduced-1,630,171-$3.36M
VERONA PHARMA PLCreduced-7,120-$205K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2024

Share positions as resolved from 13F-HR 0000895345-24-000559, largest first. % of portfolio is the value over $62,320,906, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ANNXANNEXON INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 7,056,024 shares; 2023Q2: 7,056,024 shares; 2023Q3: 7,056,024 shares; 2023Q4: 7,406,024 shares; 2024Q1: 7,406,024 shares; 2024Q2: 7,406,024 shares; 2024Q3: 7,406,024 shares 7,406,024$43.8M70.35%0Timeline
AKBAAKEBIA THREAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 16,205,119 shares; 2023Q2: 16,205,119 shares; 2023Q3: 16,205,119 shares; 2023Q4: 16,205,119 shares; 2024Q1: 13,205,119 shares; 2024Q2: 5,747,906 shares; 2024Q3: 5,747,906 shares 5,747,906$7.59M12.17%0Timeline
VERONA PHARMA PLCVERONA PHARMA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: 213,000 shares; 2024Q3: 205,880 shares 205,880$5.92M9.5%-7,120
AMWLAMERICAN WELL CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: not reported; 2024Q3: 523,785 shares 523,785$4.97M7.97%newTimeline
WHWKWHITEHAWK THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 1,630,830 shares; 2023Q2: 1,630,830 shares; 2023Q3: 1,630,830 shares; 2023Q4: 1,630,830 shares; 2024Q1: 1,630,830 shares; 2024Q2: 1,630,830 shares; 2024Q3: 659 shares 659$1.36K<0.01%-1,630,171Timeline

Sold out in Q3 2024

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
AMERICAN WELL CORPAMERICAN WELL CORP10,475,717$3.4Mshares

How Q3 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000895345-24-000559 base2024-11-13acceptance time not in the bulk data set